In this issue we are presenting another installment of our quarterly review of dealmaking—in this case November 2000-January 2001. Our data comes from Windhover's Strategic Transactions Database, which covers the deal activity within the pharmaceutical/biotechnology, medical device, and in vitrodiagnostics industries.
Some notes about our coverage: we have limited this review to human health care (thus no animal health or agricultural transactions); to mergers and acquisitions where a definitive agreement has...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?